HSBC Holdings
YMAB

HSBC Holdings’s Y-mAbs Therapeutics YMAB Stock Holding History

HSBC Holdings’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,948
Closed -$54.8K – 3202
2025
Q2 		$54.8K Buy
+11,948
New +$53.7K ﹤0.01% 2922

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HSBC Holdings's YMAB Position: Q3 2025 in Review

HSBC Holdings sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 11,948 shares — an estimated $54.8K sold.

HSBC Holdings first reported a position in YMAB in Q2 2025 and held it in 1 quarter. The position peaked at $54.8K in Q2 2025. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • HSBC Holdings reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 11,948 Y-mAbs Therapeutics shares in Q3 2025, an estimated $54.8K.
  • HSBC Holdings first reported a position in Y-mAbs Therapeutics in Q2 2025 and held it in 1 quarter.
  • HSBC Holdings's Y-mAbs Therapeutics position peaked at $54.8K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.